News

Pro Kapital's Strong Q3 2025 Financial Performance Outlined

Pro Kapital's Strong Q3 2025 Financial Performance Outlined

Management Report

Real Estate Development Overview

Tallinn Developments

In the third quarter of 2025, Pro Kapital continued to make significant progress on the Uus-Kindrali project located within Kristiine City. The White Building, which comprises 91 residential units at Talli Street 3 / Sammu Street 8, has seen remarkable advancements. Most apartments have received final finishes—tiling and painting. Client inspections are set to begin soon, with final notarial deeds anticipated to be signed in mid-November. As of the end of Q3, approximately 73.1% of units have been sold.

Additionally, another residential building featuring 90 units is under construction adjacent to the White Building at Sammu Street 10 / Seebi Street 24a. As of this report, we have completed the installation of prefabricated concrete elements up to the top floor and expect the final roof elements to be in place by early November. The targeted completion for this building is set for October to November 2026.

Within Kristiine City, planning and design for four more projects have been submitted to the Tallinn City Planning Department. These upcoming developments will contribute around 35,000 sqm of gross building area, primarily enhancing residential units—providing approximately 350 housing options while reinforcing our establishment in this urban area.

The final phase of the Kalaranna development—including four buildings and 146 units—has reached completion. A few contractors are on-site to finalize remaining tasks, and we are also enhancing marketing units to strengthen sales efforts. The sell-out rate for this project stands at around 60.9%.

Riga Developments

In early 2025, Pro Kapital successfully sold all units in the River Breeze Residence and has since begun preparations for the next project phase in Kliversala, named the Blue Marine project, which will feature 96 residential units. Construction commenced in Q3 2025, with progress on retaining wall piles nearing completion and excavation works ongoing. We are actively pursuing sales initiatives while also negotiating terms for a construction loan with a local financial institution.

Vilnius Projects

During Q3, the final stage of Šaltini? Namai Attico saw steady construction, which includes city villas and a commercial building. The villas have a nearly 43% sell-out, while the commercial building reports a little over 21% sold, achieving peak pricing in Vilnius’ competitive real estate market. We are on course for substantial completion by the end of 2025.

Our latest endeavor on Naugarduko Street involves converting a former school building into an upscale residential complex featuring around 50 luxury apartments with stunning views of Vilnius’ Old Town. The building certification process is ongoing, with an approval expected soon.

Hotel Operations Insights

Hotel performance this quarter met most expectations, although it fell slightly short of the original budget goals. Demand soared in July and August, especially in the individual leisure segment, but September's numbers did not meet expectations, attributed to weaker enterprise and MICE segment bookings. The outlook for the remaining months of the year remains optimistic despite some current soft spots in corporate demand.

Other Operational Highlights

Our Italian operations, notably Preatoni Nuda Proprietà (PNP) and Preatoni Intermediazioni Immobiliari (PII), have displayed steady performance despite the broader market slump. Interest rate hikes have temporarily influenced transaction volumes, yet the bare ownership model demonstrates strong fundamentals, leading to increased adoption of this innovative investment strategy among individuals and institutions.

In recent months, PNP has fortified its market stance, forged new collaborations, and showcased resilience amid changing market conditions. There is a gradual return of confidence in the Italian real estate sector, and as 2025 progresses, we anticipate PNP will emerge in a robust position, heightening brand presence and transaction flow.

Conclusion

The first three quarters of 2025 have heralded a period of stabilization and resolute determination across all our markets. Despite the common bureaucratic challenges and seasonal slower periods, our teams have persevered—advancing our projects steadily, focusing on results over promises.

In Tallinn, construction advancements bring value through persistent effort. Riga’s Blue Marine project reflects our commitment to hands-on building and expertise. In Vilnius, the record-setting prices in our premier project underscore our dedication to quality and reliability.

As we conclude this quarter, I express gratitude to all colleagues, partners, and shareholders for their unwavering trust and commitment. Each progressive step—irrespective of size—is a manifestation of our collective resolve and long-term vision.

Edoardo Preatoni
CEO

Key Financial Metrics

Pro Kapital reported total revenues of EUR 34.3 million over the first nine months of 2025, marking a significant increase compared to EUR 10.6 million during the same period in 2024. For the third quarter, total revenue amounted to EUR 5.7 million, eclipsing the EUR 3.7 million recorded in Q3 2024.

Real estate sales revenues are recognized upon legal title transfer to buyers. Thus, overall revenue figures depend on the construction cycle and project completion status. Revenue derived from real estate sales amplified year-over-year as we continued delivering apartments in the Kalaranna District, following initial deliveries that commenced in December 2024. The diminished revenue in Q1 to Q3 of 2024 reflects ongoing construction with limited inventory available for sale in both Riga and Vilnius.

Gross profit for the first nine months rose to EUR 11.9 million, compared to EUR 2.9 million a year earlier. In Q3, the gross profit equaled EUR 1.7 million versus EUR 0.4 million in the previous year.

The operating result for the initial nine months stood at EUR 7.7 million, contrasting with a EUR 1.7 million loss from Q3 2024. Notably, Q3 2025 reported an operating profit of EUR 0.2 million, as opposed to a EUR 0.9 million loss during the same period last year.

Over the first nine months, the net result was EUR 6.0 million profit, in comparison to a loss of EUR 4.1 million in the prior year. The Q3 net result was a minor loss of EUR 0.2 million, following a loss of EUR 1.0 million in Q3 2024.

Operating cash flow generated EUR 6.8 million during the first nine months, contrasting with EUR 10.0 million used in the same preliminary period of 2024. For Q3, cash flow indicated a decrease of EUR 1.8 million, drying up from EUR 5.5 million utilized in Q3 2024.

Net assets per share are now at EUR 1.00, reflecting an increase from EUR 0.91 at the same point last year.

Frequently Asked Questions

1. What is Pro Kapital's recent performance in terms of revenue?

Pro Kapital reported total revenues of EUR 34.3 million for the first nine months of 2025, significantly up from EUR 10.6 million during the same timeframe of 2024.

2. How many units have been sold at the White Building?

As of the latest report, approximately 73.1% of the 91 units in the White Building have been sold.

3. What is the status of the Blue Marine project in Riga?

The Blue Marine project, which features 96 residential units, commenced construction in Q3 2025 and is currently progressing with excavation works.

4. What are the company’s growth indicators?

Gross profit for the first nine months of 2025 reached EUR 11.9 million compared to EUR 2.9 million a year earlier, and Pro Kapital aims to continue its expanding trajectory in various projects.

5. Who should I contact for more information?

For inquiries, please reach out to Ann-Kristin Kuusik, CFO, at +372 614 4920 or via email at prokapital@prokapital.ee.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ractigen's LiCO™ Platform Hits Extrahepatic Milestones

Updated Category News Views 27

Breaking New Ground in RNA Therapeutics Hey, in the world of biotech, landing a meaningful delivery system is like striking gold, and it seems Ractigen Therapeutics just found a shiny nugget. Their latest study on the LiCO™ platform, living and breathing in the pages of Molecular Therapy - Nucleic Acids, maps out a path to some serious therapeutic territory. These guys...

Continue Reading
Divorce Expertise: Obenhaus Adds CDFA Credential

Updated Category News Views 46

Divorce isn't just a legal tangled mess; it's a financial minefield as well. Lindsey Obenhaus from Goranson Bain Ausley has beefed up her credentials with a Certified Divorce Financial Analyst® (CDFA®) designation, lending a sharper edge to her approach in divorce financials. When relationships turn sour, so do wallets, and Obenhaus aims to soften that blow for her...

Continue Reading
Veterans Find Community and Wellness at Orland Hills Bash

Updated Category News Views 16

A Celebration of Veterans and Community Orland Hills is set to light up with a unique Veterans Day Bash on November 1, 2026. This isn't just your run-of-the-mill community gathering; it's an event that brings together veterans from all around for a day packed with resources, education, and a chance to connect with kindred spirits—all thanks to the collaboration between...

Continue Reading
Enigmata Innovates AI Security with Finovifi Tie-Up

Updated Category News Views 94

Emerging AI Risks and Protective Measures AI in financial spaces is like walking a tightrope, there's potential but caution is crucial. Enter Enigmata, diving headfirst into this arena by shaking hands with the Finovifi Marketplace. Their aim? To bolster AI's promise without letting sensitive data slip through the cracks. Sentinel: A New Guard for Sensitive Data Let's not...

Continue Reading
Medicare Limits and Long-Term Care Planning Tips

Updated Category News Views 36

Grappling with Medicare's Gaps Most folks hear Medicare and feel a sigh of relief—thinking it's a catch-all net for healthcare in your golden years. But hold on, when it comes to long-term care, Medicare's got more holes than Swiss cheese. Cindy Couyoumjian from Cinergy Financial lays it out pretty clear: Medicare doesn't cover what it calls 'custodial care'—you know,...

Continue Reading
Lincoln Educational Faces Investor Lawsuit Over Revenue Drop

Updated Category News Views 70

Investors Face Rough Waters Okay, let’s dive into this latest mess at Lincoln Educational Services Corp. (NASDAQ:LINC). Things aren't smelling too rosy over at their headquarters. If you've got shares here, you’ll know what I mean. Back in early May, the folks running Lincoln threw a garden party talking up a 19.5% growth in student starts. Who wouldn’t get behind...

Continue Reading
Amy Johnson Steps Up as GDIT President Amid Shifts

Updated Category News Views 68

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Continue Reading
Podcast Giants Converge in Tennessee for POD U Summit

Updated Category News Views 69

Nashville Becomes a Hotspot for Podcasters Amidst the strumming guitars and honky-tonk vibes of Nashville, Tennessee transformed into the epicenter of podcasting innovation thanks to Rebel Audio's inaugural summit, POD U. Here we had big names like Mike 'Big Mike' Majlak rubbing shoulders with sports experts and media moguls—a true concoction of voices shaping the...

Continue Reading
Dimethylaminopropylamine Market Eyes $732M by 2035

Updated Category News Views 21

Surfactants and Epoxy Fuel Dimethylaminopropylamine Demand Hot off the presses, folks! Dimethylaminopropylamine, or DMAPA if you're into acronyms, is gearing up for a steady climb to a $731.9 million market value by the year 2035. That's quite the leap from the $452.6 million we saw back in 2025. According to Credence Research's latest estimates, this amine is hitching...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 93

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading

Top 5 Most Recently Viewed Articles

Infosys and Sally Beauty Forge Groundbreaking IT Partnership

Updated Category News Views 165

Infosys has officially linked arms with Sally Beauty Holdings, Inc. to kick off a major IT transformation initiative. The aim? Ramp up enterprise-scale efficiencies through hyper-automation, putting Sally Beauty on the fast track for growth and keeping it competitive in a crowded beauty sector. You know how it goes when firms try to modernize—it's always a mixed bag,...

Continue Reading
HYLENR and TakeMe2Space Join Forces for Space Innovation

Updated Category News Views 324

HYLENR and TakeMe2Space Team Up for Space Exploration HYLENR Technologies, a frontrunner in clean energy solutions, has embarked on an exciting collaboration with the innovative space-tech company, TakeMe2Space. This partnership aims to explore the potential of Low-Energy Nuclear Reaction (LENR) technology for space-based computing infrastructures. Innovative...

Continue Reading
Convoy of Hope Sets Goal to Deliver Millions of Meals

Updated Category News Views 294

Convoy of Hope's Major Initiative to Support Families As families across America face difficulties in making ends meet, there's a growing need for assistance. For just $10, it's possible to provide 30 meals to those in need. Feeding Families Nationwide In response to the increasing needs of these families, Convoy of Hope has launched an impressive initiative to deliver 10...

Continue Reading
Transforming Diets: Pulses Market Growth and Insights

Updated Category News Views 207

The Flourishing Pulses Market Driven by Plant-Based Demand The global pulses market is experiencing significant growth, with projections estimating its value to rise from USD 78.0 billion in the coming years to USD 135.2 billion. This increase represents an impressive CAGR of 5.7% throughout the forecast period. The motivation behind this expansion is largely attributed...

Continue Reading
Understanding Windtree's New Istaroxime Patent for Heart Treatments

Updated Category News Views 123

Windtree's Istaroxime Patent Issuance: A Game Changer for Heart Failure Windtree Therapeutics, Inc., a pioneering biotech firm, recently celebrated a watershed moment with the issuance of a patent for istaroxime by the United States Patent and Trademark Office. This patent pertains to a unique intravenous formulation aimed at treating acute heart failure, an ailment that...

Continue Reading